Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

SSE:603811.SS

9.6 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12014 Q22014 Q1
Revenue 185.592193.827164.753198.914153.058212.139138.628173.03147.83178.751158.063158.51159.649170.233165.865186.664171.203245.799182.213178.296151.823182.036160.241192.762146.188146.148148.106128.481123.031114.11378.17266.29682.311107.97861.09581.48470.66672.6172.61
Cost of Revenue 57.58856.35253.5378.88945.23173.95651.01963.61352.00963.5352.90946.6743.70652.68843.64852.00144.26749.60744.88549.19150.48847.25740.09849.69546.06844.55954.23445.00251.02651.80836.15930.81144.46854.84732.92538.68130.60338.82438.824
Gross Profit 128.004137.475111.223120.025107.827138.18487.608109.41795.821115.221105.154111.839115.943117.544122.217134.663126.936196.193137.328129.105101.336134.78120.143143.067100.121101.58893.87283.47972.00562.30642.01335.48537.84353.13128.1742.80240.06333.78633.786
Gross Profit Ratio 0.690.7090.6750.6030.7040.6510.6320.6320.6480.6450.6650.7060.7260.690.7370.7210.7410.7980.7540.7240.6670.740.750.7420.6850.6950.6340.650.5850.5460.5370.5350.460.4920.4610.5250.5670.4650.465
Reseach & Development Expenses 7.6619.94914.14910.32711.78111.74612.33714.7868.2759.30110.10612.9811.91810.1849.53511.6368.3618.4628.949.3964.99510.0837.0732.7889.62810.0484.1595.7646.2894.9063.0435.177015.17208.1402.3372.337
General & Administrative Expenses 26.418-68.01981.142-18.36226.044-55.03760.403-14.3624.517-51.51159.984-6.91221.855-37.23252.246-7.21920.974-31.9320.199-3.412.376-17.59912.383-2.9549.93-14.33310.997-8.56513.825-22.21515.09-1.97610.591-17.1138.04110.32511.3728.9558.955
Selling & Marketing Expenses 43.62616.62454.23854.36239.74744.51536.4437.34534.27348.32140.22845.48946.65640.83449.97258.10251.65584.62672.48664.44750.56375.5362.53981.92447.35950.08447.43334.76634.93519.15810.3547.6398.6468.1516.0829.56411.3229.9219.921
SG&A 70.044-51.396135.3868.79865.791-10.52296.84322.98558.791-3.191100.21238.57768.513.602102.21750.88372.62952.69692.68561.04862.93957.93174.92278.9757.28935.75158.4326.20148.76-3.05725.4445.66319.236-8.96214.12319.88922.69419.08419.084
Other Expenses -3.4487.92-81.422-2.0130.146-0.0680.0350.0190.51761.931-29.18229.4021.60111.97-0.308-0.746-1.263-0.4321.155-1.451-0.74-0.723-0.421-0.028-0.169-0.2150.81-1.260.8530.5210.0121.781.1761.4460.4141.910.02800
Operating Expenses 74.26546.47368.10881.13878.02877.64371.22577.79367.58368.0481.13680.95982.0375.25583.4395.10882.857118.752103.46187.46869.145103.05683.61988.00666.51376.30464.32250.57250.52535.14724.95819.94320.23829.5114.54420.65323.50219.49119.491
Operating Income 53.73991.00243.11538.88737.50955.07325.0751.97141.79649.87539.75541.20233.59658.16346.43939.07154.86668.53744.42946.20831.18829.25937.16955.72232.13525.81131.05534.3421.49927.06619.39116.69415.67825.55813.35721.77115.02913.59813.598
Operating Income Ratio 0.290.470.2620.1950.2450.260.1810.30.2830.2790.2520.260.210.3420.280.2090.320.2790.2440.2590.2050.1610.2320.2890.220.1770.210.2670.1750.2370.2480.2520.190.2370.2190.2670.2130.1870.187
Total Other Income Expenses Net -0.405-3.158-11.2941.240.146-0.0680.0350.019-16.788-0.513-0.199-0.2830.4071.283-0.308-0.746-1.263-0.432-11.173-1.451-0.74-0.723-0.421-0.028-0.169-0.2150.81-1.260.8531.299-0.5961.2791.0361.1660.4011.910.0280.2230.223
Income Before Tax 53.33487.84431.82240.12637.65555.00525.10551.9941.96249.36239.55740.9234.00259.44546.13138.32553.60268.10545.58444.75730.44828.53636.74855.69431.96625.59631.86533.0822.35328.36418.66618.43716.8526.72413.75823.68215.05713.41813.418
Income Before Tax Ratio 0.2870.4530.1930.2020.2460.2590.1810.30.2840.2760.250.2580.2130.3490.2780.2050.3130.2770.250.2510.2010.1570.2290.2890.2190.1750.2150.2570.1820.2490.2390.2780.2050.2470.2250.2910.2130.1850.185
Income Tax Expense 6.4664.0672.4485.9084.9256.461.9091.3032.34-9.3332.0124.9365.0446.6756.3535.8437.4046.0416.0365.9595.907-3.4266.02611.6457.737-0.6515.735.8954.5264.7433.0962.5642.6753.6962.0151.7393.6032.3442.344
Net Income 45.79383.62740.60843.78132.68548.94923.34850.84939.7559.05137.57636.03528.92152.69739.75132.50945.8462.41239.47938.7624.49332.22730.89344.15124.12225.73326.16727.18517.82723.62115.56915.87314.17523.02911.74321.94311.45411.07411.074
Net Income Ratio 0.2470.4310.2460.220.2140.2310.1680.2940.2690.330.2380.2270.1810.310.240.1740.2680.2540.2170.2170.1610.1770.1930.2290.1650.1760.1770.2120.1450.2070.1990.2390.1720.2130.1920.2690.1620.1530.153
EPS 0.140.2550.120.130.10.150.0710.160.120.180.160.150.120.160.170.140.140.270.120.170.0770.140.130.190.0730.110.110.120.0770.10.0470.090.0570.140.050.130.0470.0460.046
EPS Diluted 0.140.2550.120.130.10.150.0710.160.120.180.160.150.120.160.170.140.140.270.120.170.0770.140.130.190.0730.110.110.120.0770.10.0470.090.0570.140.050.130.0470.0460.046
EBITDA 54.65190.13633.96167.34654.60569.66838.20556.07345.43756.96746.32644.06947.92971.63857.87548.26358.77980.09447.9347.27237.24335.18642.52255.78537.44330.99936.17135.11822.62533.7218.67417.74420.35127.68613.62622.83718.27617.25517.255
EBITDA Ratio 0.2940.4650.2060.3390.3570.3280.2760.3240.3070.3190.2930.2780.30.4210.3490.2590.3430.3260.2630.2650.2450.1930.2650.2890.2560.2120.2440.2730.1840.2950.2390.2680.2470.2560.2230.280.2590.2380.238